GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

M K Proteins MKPL.NS · INR

N/A · NSE · 🇮🇳 India

Compare

3.95

+1.54%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹3.83bn

FY2017FY2026

Net income

₹68.3m

FY2017FY2026

Free cash flow

₹19.1m

FY2017FY2026

Shareholders' equity

₹763.0m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹3.83bn₹2.68bn₹2.46bn₹3.15bn₹2.56bn₹3.11bn₹1.94bn₹1.57bn₹1.72bn₹1.65bn
Gross profit₹144.5m₹156.5m₹192.9m₹180.6m₹186.8m₹186.2m₹71.3m₹67.7m₹79.9m₹78.4m
Operating income₹128.3m₹129.1m₹165.2m₹169.2m₹148.3m₹151.0m₹36.5m₹37.9m₹62.2m₹36.6m
Net income₹68.3m₹84.0m₹112.1m₹109.3m₹101.8m₹103.9m₹18.2m₹16.4m₹14.3m₹9.9m
Diluted earnings per share0.180.220.330.290.270.280.050.040.040.04

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹1.31bn₹1.31bn₹962.5m₹1.03bn₹861.5m₹673.5m₹565.5m₹472.6m₹561.0m₹465.7m
Cash and short-term investments₹4.4m₹338,000₹923,241₹624,836₹66,617₹12,561₹1.1m₹41,506₹2.0m₹350,352
Total liabilities₹549.0m₹611.0m₹351.7m₹533.6m₹465.4m₹380.1m₹376.0m₹301.2m₹406.0m₹423.1m
Debt₹371.4m₹387.2m₹200.8m₹455.3m₹367.8m₹251.3m₹305.7m₹261.6m₹329.8m₹313.0m
Shareholders' equity₹763.0m₹694.7m₹610.8m₹498.6m₹396.0m₹293.4m₹189.5m₹171.4m₹155.0m₹42.6m
Shares outstanding375m375m344m372m375m375m375m372m381m244m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹38.1m−₹161.3m₹324.2m−₹58.7m−₹101.2m₹55.4m−₹44.7m₹63.5m−₹120.2m−₹35.8m
Capital spending−₹19.0m−₹22.2m−₹59.0m−₹72,052−₹15.7m−₹2.6m−₹318,500−₹1.6m—−₹10.2m
Free cash flow₹19.1m−₹183.5m₹265.1m−₹58.8m−₹116.9m₹52.8m−₹45.0m₹61.9m−₹120.2m−₹46.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹1.15bn₹1.46bn₹895.6m₹324.3m₹1.15bn₹1.37bn₹394.8m₹336.9m
Gross profit₹23.7m₹36.1m₹32.1m₹15.8m₹88.9m₹55.0m₹24.4m₹28.6m
Operating income₹23.7m₹23.9m₹22.4m₹9.4m₹54.1m₹46.8m₹16.8m₹21.6m
Net income₹13.8m₹11.4m₹14.3m₹7.5m₹35.1m₹28.0m₹13.8m₹17.4m
Diluted earnings per share0.040.030.040.020.090.070.040.05
Total assets—₹1.31bn—₹800.2m—₹1.31bn—₹710.6m
Cash and short-term investments₹4.4m₹4.4m₹43.6m₹43.6m₹338,000₹338,000₹196.8m₹196.8m
Debt—₹362.1m—₹10.5m—₹377.7m—₹3.7m
Shareholders' equity₹763.0m₹763.0m₹737.3m₹737.3m₹694.7m₹694.7m₹653.0m₹653.0m

Financial ratios

Data as of 30 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2014
Gross margin3.8%5.8%7.9%5.7%7.3%6.0%—
Operating margin2.9%4.7%6.7%5.3%5.8%4.8%—
Net margin1.8%3.1%4.6%3.5%4.0%3.3%—
Return on equity9.0%12.1%18.4%21.9%25.7%35.4%—
Return on assets5.2%6.4%11.6%10.6%11.8%15.4%—
Free cash flow yield4.1%-10.0%30.2%-4.3%-6.2%4.2%—
Revenue growth42.8%9.2%-22.0%23.0%-17.7%60.3%—
Earnings growth-18.7%-25.1%2.5%7.4%-2.0%471.8%—
Current ratio2.25x2.01x2.53x1.99x1.88x1.92x—
Debt to equity0.47x0.54x0.31x0.89x0.93x0.70x—
Equity ratio58.2%53.2%63.5%48.3%46.0%43.6%—
Interest coverage6.07x11.36x14.75x8.87x16.76x18.28x—
R&D as a share of sales——————0.0%
Buybacks as a share of market value0.0%-9.2%7.5%1.0%0.0%-0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.7%4.2%10.2%
Operating income-8.8%-3.2%28.4%
Net income-14.5%-8.0%25.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin4.6%5.6%5.9%5.4%
Operating margin4.0%4.9%5.0%4.1%
Net margin2.3%3.1%3.3%2.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings22.027.125.095.391.74.818.317.622.322.3
Price to sales0.40.81.13.33.60.20.20.20.20.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3-for-1 split · 15 Mar 2024
  • 10-for-1 split · 10 Nov 2023
  • 3-for-1 split · 3 Feb 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.